Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AP
Aptevo Therapeutics Inc
APVO
Mkt Cap
$2.9M
Volume
30.85K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AP
APVO
AP
Aptevo Therapeutics Inc
APVO
News
·
Aptevo Reports 85% Remission in Q2
Mkt Cap
$2.9M
Volume
30.85K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
Aptevo Reports 85% Remission in Q2
Aptevo Therapeutics reported a net loss of $8.40 per share in Q2 2025, significantly better than analyst estimates. The company's lead bispecific antibody, mipletamig, showed promising 85% remission rates in acute myeloid leukemia trials, and raised $15.9 million in equity to extend its cash runway.
The Motley Fool · Aug 11, 2025
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Bloom Energy shares jumped 12.1% after announcing a strategic partnership with CoreWeave to deploy its fuel cells for on-site power generation at a data center. Several other stocks also saw significant pre-market movements, both positive and negative.
Benzinga · Jul 17, 2024
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita Coco Company (COCO), AMC Entertainment (AMC), Hyperfine (HYPR), Aptevo Therapeutics (APVO) and CLEAR Secure (YOU).
Zacks Investment Research · May 28, 2024
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Groupon (GRPN), Aptevo Therapeutics (APVO), NewJersey Resources (NJR), American Water Works (AWK) and Frontdoor (FTDR).
Zacks Investment Research · Apr 24, 2024
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
Aptevo (APVO) plunges after it issues secondary shares, which are not only issued at a significant discount but also substantially dilute the existing shareholder base.
Zacks Investment Research · Apr 16, 2024
Nasdaq Jumps 250 Points; Crude Oil Down 1%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26. Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report Leading and Lagging Sectors Information technology shares rose by 2.2% on Thursday. In trading on Thursday, energy shares fell by 0.3%. Top Headline Constellation Brands Inc (NYSE: STZ) reported better-than-expected fourth-quarter earnings. Constellation Brands reported fourth-quarter FY24 sales growth of 7.1% year-on-year to $2.14 billion, beating the analyst consensus estimate of $2.10 billion. Comparable EPS, excluding Canopy EIE, was $2.30. Comparable EPS of $2.26 beat the consensus estimate of $2.09. Equities Trading UP Rallybio Corporation (NASDAQ: RLYB) shares shot up 87% to $3.0419 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Shares of Eliem ...
Benzinga · Apr 11, 2024
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents. Fastenal shares dipped 6.7% to $69.73 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Rallybio Corporation (NASDAQ: RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rent the Runway, Inc. (NASDAQ: RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance. Eliem Therapeutics, Inc. (NASDAQ: ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement. Akanda Corp. (NASDAQ: AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company. Candel Therapeutics, Inc. (NASDAQ: CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof ...
Benzinga · Apr 11, 2024
Dow Dips 100 Points; CarMax Earnings Miss Views
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. The Dow traded down 0.35% to 38,328.18 while the NASDAQ rose 0.50% to 16,251.71. The S&P 500 also rose, gaining, 0.03% to 5,162.19.Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report Leading and Lagging Sectors Information technology shares rose by 0.1% on Thursday. In trading on Thursday, financial shares fell by 1.3%. Top Headline CarMax Inc (NYSE: KMX) reported weaker-than-expected fourth-quarter earnings. CarMax reported a fourth-quarter FY24 sales decline of 1.7% year-on-year to $5.63 billion, missing the analyst consensus estimate of $5.79 billion. EPS of 32 cents missed the consensus estimate of 49 cents. Equities Trading UP Rallybio Corporation (NASDAQ: RLYB) shares shot up 73% to $2.8150 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Shares of Eliem Therapeutics, Inc. (NASDAQ:
Benzinga · Apr 11, 2024
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94. The S&P 500 also rose, gaining, 0.17% to 5,169.21. Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report Leading and Lagging Sectors Real estate shares rose by 0.6% on Thursday. In trading on Thursday, financial shares fell by 0.1%. Top Headline Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%. Equities Trading UP Rallybio Corporation (NASDAQ: RLYB) shares shot up 95% to $3.1793 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Shares of Eliem Therapeutics, Inc. (NASDAQ: ELYM) got a boost, ...
Benzinga · Apr 11, 2024
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Rent the Runway, Inc. (NASDAQ: RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company. TuanChe Limited (NASDAQ: TC) shares gained 24.4% to $2.24 in pre-market trading after falling 8% on Wednesday. Verb Technology Company, Inc. (NASDAQ: VERB) gained 18.5% to $0.2156 in pre-market trading after gaining 4% on Wednesday. Vera Therapeutics, Inc. (NASDAQ: VERA) climbed 13.1% to $47.06 in pre-market trading ...
Benzinga · Apr 11, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
AP
APVO
Aptevo Therapeutics Inc
Buy
Sell
Market
Limit
Soon
APVO
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any APVO yet.
Related Tickers
Earnings